Record Display for the EPA National Library Catalog

RECORD NUMBER: 30 OF 280

Main Title Assessment of Oil Shale Retort Wastewater Treatment and Control Technology: Phases I and II.
Author Klieve, J. R. ; Rawlinss, G. D. ; Hoeflein, J. R. ;
CORP Author Monsanto Research Corp., Dayton, OH.;Industrial Environmental Research Lab.-Cincinnati, OH.
Year Published 1981
Report Number EPA-68-03-2801; EPA-600/7-81-081;
Stock Number PB81-187288
Additional Subjects Water pollution control ; Oil shale ; Technology ; Assessments ; Industrial waste treatment ; Surface water ; Ground water ; Design criteria ; Process charting ;
Internet Access
Description Access URL
https://nepis.epa.gov/Exe/ZyPDF.cgi?Dockey=300012ER.PDF
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB81-187288 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 100p
Abstract
Oil shale retorting is a synthetic fuel production technology on the verge of commercialization in the United States. In order to ensure that the emerging oil shale industry will have minimal adverse effects upon surface and/or groundwater where recoverable reserves of oil shale are found, demonstrated technologies to upgrade oil shale wastewaters must be available to developers. To this end, the U.S. Environmental Protection Agency has contracted with Monsanto Research Corporation to conduct a three-year, five-phased study to: (1) summarize known information concerning oil shale retort wastewater sources and characteristics; (2) identify potentially applicable control technologies capable of treating the identified wastewater streams; and (3) design, construct, and operate pilot-plant facilities to evaluate the selected technologies. This report presents results of Phases I and II, in which literature and other information sources were surveyed to obtain relevant data about oil shale retorting technologies, wastewater sources and characteristics, potential wastewater uses, and potentially applicable treatment technologies. As a result of the study, data gaps were identified, and recommendations for bench-scale treatability studies were made.